Prelamin A and subsequently mature Lamin A/C protein constitutes the nuclear lamina and nuclear matrix, and involves in a variety of nuclear activities to keep cellular stability and activity 22,23,24
FDA materials instead discuss GHK-Cu in compounding contexts, including category updates for non-injectable routes and safety concerns for injectable routes [8], 19
Peptides (TB-500, GHK-Cu, and Ipamorelin) target narrower recovery pathways, making direct comparisons useful for understanding the scope of each compound's preclinical evidence
Dosing: Provider-determined (Topical cream)
It is often preferred due to its high selectivity and reduced side effects
Evening administration operates through a different pathway